We are live on ! Find out more
GRCL

Gracell Biotechnologies Inc. American Depositary Shares

Delisted

GRCL was delisted on the 21st of February, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
Temasek Holdings
1
Temasek Holdings
Singapore
$54.5M
O
2
OrbiMed
New York
$43.4M
FLSM
3
Frazier Life Sciences Management
California
$17.1M -$1.04M -334,422 -10%
CII
4
Capital International Inc
California
$16.5M +$2.05M +658,219 +28%
EC
5
EcoR1 Capital
California
$10.6M +$1.12M +361,600 +23%
Federated Hermes
6
Federated Hermes
Pennsylvania
$7.14M
BlackRock
7
BlackRock
New York
$5.55M +$263K +84,517 +9%
VC
8
Vivo Capital
California
$5.29M
PBA
9
Paradigm Biocapital Advisors
New York
$4.31M
Morgan Stanley
10
Morgan Stanley
New York
$3.02M -$245K -78,758 -13%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$1.88M -$2.33M -750,092 -69%
CIS
12
Capital International Sarl
California
$1.66M +$230K +74,033 +32%
SSA
13
Schonfeld Strategic Advisors
New York
$1.42M +$802K +257,924 New
State of Wisconsin Investment Board
14
State of Wisconsin Investment Board
Wisconsin
$681K
Ensign Peak Advisors
15
Ensign Peak Advisors
Utah
$554K
Invesco
16
Invesco
Georgia
$515K +$60.5K +19,443 +26%
ECM
17
ExodusPoint Capital Management
New York
$481K +$272K +87,529 New
Bank of America
18
Bank of America
North Carolina
$322K -$86.3K -27,744 -32%
Renaissance Technologies
19
Renaissance Technologies
New York
$274K +$81.8K +26,300 +111%
Barclays
20
Barclays
United Kingdom
$222K +$126K +40,430 New
Geode Capital Management
21
Geode Capital Management
Massachusetts
$182K
Goldman Sachs
22
Goldman Sachs
New York
$134K -$249K -80,141 -77%
VIA
23
Vident Investment Advisory
Georgia
$110K
Wells Fargo
24
Wells Fargo
California
$28K -$13.7K -4,400 -46%
Citigroup
25
Citigroup
New York
$17K -$1.14K -366 -11%